Evidence map›Paper›PMID 42431873›Full record

ArticleTranslational psychiatry2026

Phenotyping antidepressant treatment response with deep learning in electronic health records.

Yi-Han Sheu, Colin Magdamo, Matthew Miller, Sudeshna Das, Deborah Blacker, Jordan W Smoller

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yi-Han SheuCenter for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA. ysheu@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-2767-0851
Colin MagdamoDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Matthew MillerBouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
Sudeshna DasDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9486-6811
Deborah BlackerDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Jordan W SmollerCenter for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Alberto Serrano-Pozo · 2019 to 2026
$36.5M
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related DementiasR01AG058063 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI MARK W ALBERS, PETER Karl SORGER · 2018 to 2026
$7.8M
PsycheMERGE: Leveraging electronic health records and genomics for mental health researchR01MH118233 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DAVIS, LEA K, SMOLLER, JORDAN W · 2019 to 2022
$3.1M
2/7 PsycheMERGE: Advancing Precision PsychiatryR01MH137218 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI JORDAN W SMOLLER · 2024 to 2026
$2.4M
Uncertainty-Aware Prediction of Differential Responses to Antidepressants: Leveraging EHR and GenomicsK08MH141190 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI Yi-Han Sheu · 2026 to 2026
$791k
Harvard T.H. Chan School of Public Health Taiwanese Physicians ScholarshipNIA NIH HHS P30 AG062421NIA NIH HHS R01 AG058063NIMH NIH HHS K08 MH141190NIMH NIH HHS R01 MH118233NIMH NIH HHS R01 MH137218U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) K08MH141190U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH118233U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH137218U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P30AG062421U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG058063
6 · The paper itself

Abstract

Efficient, accurate phenotyping for antidepressant treatment response in electronic health records (EHRs) could facilitate precision psychiatry applications but remains a challenge. Increasingly, artificial intelligence methods using deep learning applied to clinical data have shown promise in complex classification problems. Here, we systematically evaluate the performance of eight deep learning-based language models in classifying response to antidepressants in a large real-world healthcare setting. We obtained data spanning 1990-2018 for adults with depression and a co-occurring antidepressant prescription from the EHR data warehouse of the Mass General Brigham healthcare system (n = 111,563). Clinical note sets (n = 3996) were collected for 4-12 weeks after antidepressant initiation, and were manually reviewed to classify response status as "improved" or "no evidence of improvement" in depression symptoms for model development and evaluation. The phenotyping models performed well, with the majority having areas under the receiver operator curve (AUROC) exceeding 0.80. For example, BERT-large with sliding window had an AUROC = 0.84 and PPV = 0.80 at a specificity of 0.87. Our results indicate that deep learning language models applied to EHR data can accurately classify antidepressant response in a real-world healthcare setting.

Indexed as

Antidepressive AgentsDeep LearningElectronic Health RecordsAdultFemaleHumansMaleMiddle AgedPhenotypePredictive Learning ModelsAntidepressive Agents

Identifiers

PMID42431873
PMCPMC13642340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.